{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:34:08Z","timestamp":1792794848377,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.taap.2023.116509","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T16:47:13Z","timestamp":1680713233000},"page":"116509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Suppression of SIRT1\/FXR signaling pathway contributes to oleanolic acid-induced liver injury"],"prefix":"10.1016","volume":"467","author":[{"given":"Songjie","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2023.116509_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22111915","article-title":"Oleanolic acid and its derivatives: biological activities and therapeutic potential in chronic diseases","volume":"22","author":"Ayeleso","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.taap.2023.116509_bb0010","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.wem.2021.03.005","article-title":"Cardiac arrest by aconite poisoning","volume":"32","author":"Blasco Mari\u00f1o","year":"2021","journal-title":"Wilderness Environ. Med."},{"key":"10.1016\/j.taap.2023.116509_bb0015","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/hep.30275","article-title":"Fine-tuning of Sirtuin 1 expression is essential to protect the liver from Cholestatic liver disease","volume":"69","author":"Blokker","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2023.116509_bb0020","doi-asserted-by":"crossref","first-page":"158733","DOI":"10.1016\/j.bbalip.2020.158733","article-title":"Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis","volume":"1865","author":"Carino","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.taap.2023.116509_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/nu14030623","article-title":"Oleanolic acid: extraction, characterization and biological activity","volume":"14","author":"Castellano","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.taap.2023.116509_bb0030","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jhep.2012.08.008","article-title":"miR-34a\/SIRT1\/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease","volume":"58","author":"Castro","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.taap.2023.116509_bb0035","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1507\/endocrj.K07E-103","article-title":"Molecular basis of endocrine regulation by orphan nuclear receptor small heterodimer partner","volume":"55","author":"Chanda","year":"2008","journal-title":"Endocr. J."},{"key":"10.1016\/j.taap.2023.116509_bb0040","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.tem.2013.12.001","article-title":"SIRT1 and other sirtuins in metabolism","volume":"25","author":"Chang","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.taap.2023.116509_bb0045","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejphar.2015.08.029","article-title":"Oleanolic acid attenuates obstructive cholestasis in bile duct-ligated mice, possibly via activation of NRF2-MRPs and FXR antagonism","volume":"765","author":"Chen","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2023.116509_bb0050","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s11695-009-0052-z","article-title":"SIRT1 transcription is decreased in visceral adipose tissue of morbidly obese patients with severe hepatic steatosis","volume":"20","author":"Costa Cdos","year":"2010","journal-title":"Obes. Surg."},{"key":"10.1016\/j.taap.2023.116509_bb0055","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20190189","article-title":"The role of sirtuin 1 and its activator, resveratrol in osteoarthritis","volume":"39","author":"Deng","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.taap.2023.116509_bb0060","doi-asserted-by":"crossref","first-page":"1308749","DOI":"10.1155\/2020\/1308749","article-title":"Development and evaluation of oleanolic acid dosage forms and its derivatives","volume":"2020","author":"Feng","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.taap.2023.116509_bb0065","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3389\/fphar.2020.00747","article-title":"LC-MS-based metabolomic study of oleanolic acid-induced hepatotoxicity in mice","volume":"11","author":"Feng","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2023.116509_bb0070","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/jat.4298","article-title":"Farnesoid X receptor contributes to oleanolic acid-induced cholestatic liver injury in mice","volume":"42","author":"Feng","year":"2022","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.taap.2023.116509_bb0075","doi-asserted-by":"crossref","first-page":"G1202","DOI":"10.1152\/ajpgi.00104.2012","article-title":"The novel growth factor, progranulin, stimulates mouse cholangiocyte proliferation via sirtuin-1-mediated inactivation of FOXO1","volume":"303","author":"Frampton","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.taap.2023.116509_bb0080","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00125-014-3485-4","article-title":"SIRT1 activation ameliorates hyperglycaemia by inducing a torpor-like state in an obese mouse model of type 2 diabetes","volume":"58","author":"Gilbert","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.taap.2023.116509_bb0085","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1007\/s12072-021-10241-3","article-title":"Herbal and dietary supplement-induced liver injury in Taiwan: comparison with conventional drug-induced liver injury","volume":"15","author":"Huang","year":"2021","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.taap.2023.116509_bb0090","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1053\/j.gastro.2013.12.029","article-title":"Intestine-specific deletion of SIRT1 in mice impairs DCoH2-HNF-1\u03b1-FXR signaling and alters systemic bile acid homeostasis","volume":"146","author":"Kazgan","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2023.116509_bb0095","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/164_2019_231","article-title":"Targeting FXR in cholestasis","volume":"256","author":"Keitel","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.taap.2023.116509_bb0100","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cmet.2009.09.009","article-title":"FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states","volume":"10","author":"Kemper","year":"2009","journal-title":"Cell Metab."},{"key":"10.1016\/j.taap.2023.116509_bb0105","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/B978-0-12-407766-9.00016-X","article-title":"Sirtuin 1 deacetylase: a key regulator of hepatic lipid metabolism","volume":"91","author":"Kemper","year":"2013","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.taap.2023.116509_bb0110","first-page":"22","article-title":"Nephrotoxicity of herbal products in Europe-a review of an underestimated problem","author":"Kili\u015b-Pstrusi\u0144ska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2023.116509_bb0115","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/hep.25740","article-title":"Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2023.116509_bb0120","doi-asserted-by":"crossref","first-page":"12604","DOI":"10.1074\/jbc.M109.094524","article-title":"A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition","volume":"285","author":"Lee","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2023.116509_bb0125","doi-asserted-by":"crossref","first-page":"8856","DOI":"10.1074\/jbc.M306422200","article-title":"The farnesoid X receptor controls gene expression in a ligand- and promoter-selective fashion","volume":"279","author":"Lew","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2023.116509_bb0130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-2004-823099","article-title":"The pathology of cholestasis","volume":"24","author":"Li","year":"2004","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.taap.2023.116509_bb0135","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1210\/me.2010-0014","article-title":"Farnesoid X receptor activation mediates head-to-tail chromatin looping in the Nr0b2 gene encoding small heterodimer partner","volume":"24","author":"Li","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.taap.2023.116509_bb0140","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0378-8741(95)90032-2","article-title":"Pharmacology of oleanolic acid and ursolic acid","volume":"49","author":"Liu","year":"1995","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.taap.2023.116509_bb0145","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jep.2005.05.024","article-title":"Oleanolic acid and ursolic acid: research perspectives","volume":"100","author":"Liu","year":"2005","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.taap.2023.116509_bb0150","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/liv.13940","article-title":"Oleanolic acid reprograms the liver to protect against hepatotoxicants, but is hepatotoxic at high doses","volume":"39","author":"Liu","year":"2019","journal-title":"Liver Int."},{"key":"10.1016\/j.taap.2023.116509_bb0155","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.3390\/molecules18033060","article-title":"Repeated oral administration of oleanolic acid produces cholestatic liver injury in mice","volume":"18","author":"Lu","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.taap.2023.116509_bb0160","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.celrep.2014.01.031","article-title":"The SIRT1 activator SRT1720 extends lifespan and improves health of mice fed a standard diet","volume":"6","author":"Mitchell","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.taap.2023.116509_bb0165","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/hep.28813","article-title":"Liver injury from herbal and dietary supplements","volume":"65","author":"Navarro","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2023.116509_bb0170","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3748\/wjg.15.1677","article-title":"Bile-acid-induced cell injury and protection","volume":"15","author":"Perez","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.taap.2023.116509_bb0175","doi-asserted-by":"crossref","first-page":"9793","DOI":"10.1073\/pnas.0802917105","article-title":"Sirt1 protects against high-fat diet-induced metabolic damage","volume":"105","author":"Pfluger","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2023.116509_bb0180","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.phytochem.2011.12.022","article-title":"Oleanolic acid","volume":"77","author":"Pollier","year":"2012","journal-title":"Phytochemistry"},{"key":"10.1016\/j.taap.2023.116509_bb0185","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1128\/MCB.05988-11","article-title":"Hepatic deletion of SIRT1 decreases hepatocyte nuclear factor 1\u03b1\/farnesoid X receptor signaling and induces formation of cholesterol gallstones in mice","volume":"32","author":"Purushotham","year":"2012","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.taap.2023.116509_bb0190","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1248\/bpb.b18-00028","article-title":"Dysregulation of BSEP and MRP2 may play an important role in isoniazid-induced liver injury via the SIRT1\/FXR pathway in rats and HepG2 cells","volume":"41","author":"Qu","year":"2018","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.taap.2023.116509_bib281","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.clinre.2015.12.017","article-title":"Bile acids in drug induced liver injury: Key players and surrogate markers","volume":"40","author":"Schadt","year":"2016","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.taap.2023.116509_bb0195","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3109\/07853890.2010.547211","article-title":"Sirtuin 1 in lipid metabolism and obesity","volume":"43","author":"Schug","year":"2011","journal-title":"Ann. Med."},{"key":"10.1016\/j.taap.2023.116509_bb0200","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1053\/j.gastro.2019.02.002","article-title":"Incidence and etiology of drug-induced liver injury in mainland China","volume":"156","author":"Shen","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2023.116509_bb0205","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.taap.2018.12.012","article-title":"Dictamnine-induced hepatotoxicity in mice: the role of metabolic activation of furan","volume":"364","author":"Shi","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2023.116509_bb0210","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/86871","article-title":"Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism","volume":"27","author":"Shih","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.taap.2023.116509_bb0215","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1002\/hep.27171","article-title":"Transcriptional dynamics of bile salt export pump during pregnancy: mechanisms and implications in intrahepatic cholestasis of pregnancy","volume":"60","author":"Song","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2023.116509_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17091488","article-title":"Drug, herb, and dietary supplement hepatotoxicity","volume":"17","author":"Teschke","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2023.116509_bb0225","article-title":"Traditional Chinese medicine (TCM) and herbal hepatotoxicity: RUCAM and the role of novel diagnostic biomarkers such as microRNAs","volume":"3","author":"Teschke","year":"2016","journal-title":"Medicines (Basel)"},{"key":"10.1016\/j.taap.2023.116509_bb0230","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/hep.30509","article-title":"The nonsteroidal farnesoid X receptor agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with primary sclerosing cholangitis","volume":"70","author":"Trauner","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2023.116509_bb0235","doi-asserted-by":"crossref","first-page":"105422","DOI":"10.1016\/j.envint.2019.105422","article-title":"Cholestatic liver injury induced by food additives, dietary supplements and parenteral nutrition","volume":"136","author":"Vilas-Boas","year":"2020","journal-title":"Environ. Int."},{"key":"10.1016\/j.taap.2023.116509_bb0240","doi-asserted-by":"crossref","first-page":"147567","DOI":"10.1016\/j.brainres.2021.147567","article-title":"Resveratrol reverses hippocampal synaptic markers injury and SIRT1 inhibition against developmental Pb exposure","volume":"1767","author":"Wang","year":"2021","journal-title":"Brain Res."},{"key":"10.1016\/j.taap.2023.116509_bb0245","doi-asserted-by":"crossref","first-page":"109619","DOI":"10.1016\/j.cbi.2021.109619","article-title":"Anticancer effects of oleanolic acid on human melanoma cells","volume":"347","author":"Woo","year":"2021","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.taap.2023.116509_bb0250","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.4254\/wjh.v13.i9.1019","article-title":"Herbal and dietary supplement induced liver injury: highlights from the recent literature","volume":"13","author":"Woo","year":"2021","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.taap.2023.116509_bb0255","doi-asserted-by":"crossref","first-page":"361","DOI":"10.36468\/pharmaceutical-sciences.657","article-title":"Oleanolic acid induces apoptosis and necrosis in LO2 cells","volume":"82","author":"Xiao","year":"2020","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.taap.2023.116509_bb0260","doi-asserted-by":"crossref","first-page":"913367","DOI":"10.3389\/fphar.2022.913367","article-title":"Trilobatin, a naturally occurring food additive, ameliorates exhaustive exercise-induced fatigue in mice: involvement of Nrf2\/ARE\/ferroptosis signaling pathway","volume":"13","author":"Xiao","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2023.116509_bb0265","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3389\/fphar.2017.00260","article-title":"Activation of Sirt1\/FXR signaling pathway attenuates triptolide-induced hepatotoxicity in rats","volume":"8","author":"Yang","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2023.116509_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2016.10.016","article-title":"Protective effects of SRT1720 via the HNF1\u03b1\/FXR signalling pathway and anti-inflammatory mechanisms in mice with estrogen-induced cholestatic liver injury","volume":"264","author":"Yu","year":"2016","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.taap.2023.116509_bb0275","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jep.2014.08.037","article-title":"Neuroprotection or neurotoxicity? New insights into the effects of Acanthopanax senticosus harms on nervous system through cerebral metabolomics analysis","volume":"156","author":"Zhang","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.taap.2023.116509_bb0280","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/jhbp.537","article-title":"Modulation of transport and metabolism of bile acids and bilirubin by chlorogenic acid against hepatotoxicity and cholestasis in bile duct ligation rats: involvement of SIRT1-mediated deacetylation of FXR and PGC-1\u03b1","volume":"25","author":"Zhu","year":"2018","journal-title":"J. Hepatobiliary. Pancreat. Sci."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X23001485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X23001485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T01:13:58Z","timestamp":1736385238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X23001485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":57,"alternative-id":["S0041008X23001485"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2023.116509","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suppression of SIRT1\/FXR signaling pathway contributes to oleanolic acid-induced liver injury","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2023.116509","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116509"}}